Humana (NYSE:HUM) Hits New 1-Year High – Still a Buy?

Humana Inc. (NYSE:HUM)’s share price reached a new 52-week high on Thursday . The company traded as high as $428.88 and last traded at $411.2380, with a volume of 194111 shares trading hands. The stock had previously closed at $407.78.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent analyst reports. Raymond James Financial set a $300.00 price objective on Humana in a report on Tuesday, July 7th. The Goldman Sachs Group upped their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. UBS Group reissued a “neutral” rating on shares of Humana in a report on Monday, June 15th. Needham & Company LLC began coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating for the company. Finally, Mizuho upped their target price on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $325.87.

Humana Price Performance

The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market capitalization of $48.09 billion, a PE ratio of 42.84, a P/E/G ratio of 2.09 and a beta of 0.71. The company’s 50-day simple moving average is $354.03 and its 200-day simple moving average is $260.19.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the previous year, the company posted $11.58 earnings per share. The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 9.53 earnings per share for the current year.

Institutional Trading of Humana

A number of institutional investors have recently bought and sold shares of HUM. Aberdeen Group plc raised its position in shares of Humana by 18.1% in the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after acquiring an additional 9,960 shares during the last quarter. Ninety One UK Ltd grew its stake in Humana by 57.2% in the 4th quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after acquiring an additional 40,958 shares during the period. Sustainable Insight Capital Management LLC raised its holdings in Humana by 23.7% in the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Humana by 287.5% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,512 shares of the insurance provider’s stock worth $14,699,000 after purchasing an additional 38,962 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.